Press Releases

DUBAI, the United Arab Emirates, June 07, 2024 (GLOBE NEWSWIRE) -- OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for June 7, 2024.

OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

OKX today announced that it will list Ultiverse's ULTI token on its perpetual futures market on June 7 at 7:30 AM (UTC), enabling customers to long or short ULTI with up to 50x... (continue reading...)

DUBAI, the United Arab Emirates, June 07, 2024 (GLOBE NEWSWIRE) -- OKX, a leading crypto exchange by trading volume and a leading Web3 technology company, has issued updates for June 7, 2024.

OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

OKX today announced that it will list Ultiverse's ULTI token on its perpetual futures market on June 7 at 7:30 AM (UTC), enabling customers to long or short ULTI with up to 50x... (continue reading...)

ZIBO, China, June 7, 2024 /PRNewswire/ -- On June 4, Sun Juan, a resident of Zhujiahu Village in Yanya Town, Yiyuan County, Shandong Province, came to the solar-powered charging pile near her home to charge her new energy vehicle while she had to travel five kilometers to the town for charging previously.

"It used to be inconvenient to charge my car because the charging pile was far from my village. Now, it only takes a few minutes to get there with the charging... (continue reading...)

VANCOUVER, BC / ACCESSWIRE / June 7, 2024 / Omega Pacific Resources Inc. (CSE:OMGA)(OTCQB: OMGPF)(FSE:Q0F) ("Omega" or the "Company") is pleased to announce that after successfully completing the application process it has been approved by FINRA for quotation in the U.S. The Company's common shares will begin being quoted on the OTCQB today, under the stock symbol "OMGPF" and will remain listed on the CSE under the ticker symbol "OMGA." The Company has also completed... (continue reading...)

TAINAN, June 7, 2024 /PRNewswire/ -- MLB (Merry Life Biomedical Company, Ltd., Taiwan: https://www.tmlbio.com/), a biomedical company, announced that the U.S. Food and Drug Administration (FDA) has approved IND application for TML-6, an novel drug to treat Alzheimer's disease (AD), enabling a Phase 1 clinical trial to be initiated this July. Advancing TML-6 into clinical trial is a critical milestone for MLB to develop a new era multi-target drug for AD since 2018.

... (continue reading...)